About the HIP Scientific Partners
With ten founding institutional members on five continents, the landmark HIP Scientific Partner Network is the largest systems immunology collaboration in history.
Allen Institute
The Allen Institute is a 501(c)(3) nonprofit research organization dedicated to understanding life and advancing health. Through bold moonshot initiatives combining big science, team science, and open science, they work to push beyond conventional limits and create new foundational knowledge. By openly sharing its data, tools, and models, the Allen Institute accelerates scientific progress and improves lives everywhere.
The European Hub for HIP: DZNE, University of Bonn and the Swarm Learning Consortium:
The German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE), the Cluster of Excellence ImmunoSensation2 at the University of Bonn, as well as the Consortium on “Swarm Learning for Precision Medicine in Infectious Diseases and Pandemic Preparedness” are an interconnected research ecosystem focusing on innovative approaches to medical data analysis and research, with DZNE providing expertise in neurodegenerative diseases and ImmunoSensation2 contributing immunological research capabilities. DZNE serves as the current host of the “DZNE Swarm Learning Hub” which provides the technological framework for secure, privacy-preserving collaborative AI applications in medical research. DZNE, ImmunoSensation2, and the Swarm Learning Consortium collectively serve as the European Hub for HIP.
The Human Functional Genomics Project:
Coordinated from the Radboud University Medical Center in Nijmegen, the Netherlands, the Human Functional Genomics Project is a large-scale project that aims to identify the genetic and environmental factors that impact inter-individual variation in immune responses in homeostasis and immune-mediated diseases. The consortium is an international network of nine academic institutions on four continents, currently investigating more than 25 cohorts of healthy populations and diverse immune-mediated diseases around the world.
HypoVax Global:
The HypoVax Global Knowledge hub aims to tackle the problem of vaccine hyporesponsiveness by creating a platform that mobilizes global researchers working in diverse fields related to vaccines to form a strong network focused on the Global South. The hub was initiated through a Spinoza Prize awarded to Professor Maria Yazdanbakhsh of Leiden University Medical Center working closely with collaborative partners around the world. The hub’s vision is that global researchers work together towards a common goal of finding interventions to reverse vaccine hyporesponsiveness.
RIKEN
RIKEN, a National Research and Development Agency, is Japan’s largest comprehensive research institution renowned for high-quality research in a diverse range of scientific disciplines. Founded in 1917, initially as a private research foundation, RIKEN has grown rapidly in size and scope, today encompassing a network of world-class research centers and institutes across Japan.
The Center for Human Systems Immunology at Stanford Medicine
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies. Our close proximity to the resources of the university — including the Schools of Business, Law, Humanities and Sciences, and Engineering, our seamless relationship with our affiliated adult and children’s hospitals, and our ongoing associations with the entrepreneurial endeavors of Silicon Valley, make us uniquely positioned to accelerate the pace at which new knowledge is translated into tangible health benefits.
The Sustainable Sciences Institute (SSI)
The Sustainable Sciences Institute (SSI) is a non-profit organization dedicated to developing scientific research capacity in areas of the world with pressing health problems. Headquartered in Oakland, California, SSI’s main research center is in Nicaragua where, for over 25 years, it has carried out research on infectious diseases and provided on-site scientific training funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the World Health Organization, private foundations and individual donors. SSI empowers local scientists through training in laboratory methods, diagnostics, epidemiology, grant-writing, manuscript-writing, and bioinformatics. Its programs focus on infectious diseases, including arboviruses, influenza, and hepatitis C, while leveraging community engagement and sustainable research practices. A cornerstone of this work is SSI’s leadership in long-standing cohort studies in Nicaragua, which provide unique insights into dengue, Zika, chikungunya, and other emerging infections. SSI’s founder and President, Dr. Eva Harris, was awarded a MacArthur Fellowship in 1997. Using these funds, she founded SSI together with Dr. Josefina Coloma, SSI’s Executive Director, and others in 1998. In partnership with Dr. Harris’s group at the University of California, Berkeley, and Nicaraguan colleagues, SSI coordinates the Pediatric Dengue Cohort Study (PDCS), a 21-year prospective cohort study based in Managua, the capital of Nicaragua.
Technion – Israel Institute of Technology
The Systems Immunology & Precision Medicine Laboratory at the Technion – Israel Institute of Technology, established in 2012, focuses on developing novel analytics for studying the immune system and applies these tools to investigate the drivers of immune variation and advance immune-based precision medicine.
WEHI (The Walter and Eliza Hall Institute of Medical Research)
WEHI is where brilliant minds collaborate and innovate to make life-changing scientific discoveries that help people live healthier for longer. Our medical researchers have been serving the community for more than 100 years, making transformative discoveries in cancer, infection and immunity, and lifelong health. At WEHI, we are brighter together.
CSEI, The Yale Center for Systems and Engineering Immunology at Yale University:
The CSEI at the Yale University School of Medicine (YSM) is a worldclass center of research for systems, quantitative, and synthetic immunology. It brings together Yale faculty and trainees from numerous departments across Yale University, including the School of Medicine, School of Engineering and Applied Science, and the Faculty of Arts and Sciences to develop cutting-edge experimental, computational, and AI technologies to predict and engineer immune system behavior in health and disease.
PHOTO CREDIT: Constance Brukin/CSHL
